[Calcium antagonists decrease migration and proliferation activity of human plaque monocytes].
Heimerl
J
J
Medizinische Klinik I, Ludwig-Maximilians-Universität München.
Höfling
B
B
Heidemann
P
P
Emberger
C
C
Kandolf
R
R
Bauriedel
G
G
D001161:Arteriosclerosis / Q000473:pathology*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects*; D002465:Cell Movement / Q000187:drug effects*; D002478:Cells, Cultured; D003324:Coronary Artery Disease / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009000:Monocytes / Q000187:drug effects* / Q000473:pathology; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000473:pathology
D002121:Calcium Channel Blockers
Calcium-Antagonisten vermindern Migrations- und Proliferations-Aktivität humaner Plaque-Myozyten.